Brooks Laboratories approved selling 51,220 shares in Brooks Steriscience for ₹106.33 crore. The sale reduces its stake to 32.67%, with proceeds earmarked for growth and expansion.

Brooks Laboratories Sells ₹106 Crore Stake in Subsidiary

Brooks Laboratories will sell 51,220 equity shares in its investee company, Brooks Steriscience Limited, for ₹106.33 crore to Steriscience Specialities Private Limited.

Reader Takeaway: Monetizes investment for growth capital; retains significant minority stake.

What just happened

The Board of Directors of Brooks Laboratories Limited approved the sale of 51,220 equity shares in Brooks Steriscience Limited. The buyer is Steriscience Specialities Private Limited, and the transaction involves a cash consideration of ₹106.33 crore, priced at ₹20,760 per share.

Why this matters

This partial divestment will provide Brooks Laboratories with significant capital, ₹106.33 crore, to fuel its growth strategy, including operational expansion and capacity enhancement. The company will retain a strategic interest with a 32.67% stake.

The backstory

Brooks Laboratories held a 49.00% stake in Brooks Steriscience Limited prior to this transaction. This sale represents a strategic move to unlock value from its investment and redeploy capital.

What changes now

Brooks Laboratories' shareholding in Brooks Steriscience will decrease from 49.00% to 32.67%. The company will continue to hold 1,02,440 equity shares. The received funds are designated for expansion, capacity enhancement, business opportunities, and general corporate purposes.

Risks to watch

Investors should monitor the effective deployment of the ₹106.33 crore proceeds to ensure they translate into tangible business growth and improved financial performance.

Peer comparison

Information on specific transactions or stake sales in subsidiaries by peers is not readily available in the filing.

Context metrics (time-bound)

Transaction value: ₹106.33 crore.
Number of shares sold: 51,220.
Sale price per share: ₹20,760.
Original stake: 49.00%.
New stake: 32.67%.

What to track next

Track the company's announcements regarding the utilization of the ₹106.33 crore funds and any updates on the strategic direction of Brooks Steriscience Limited, where Brooks Laboratories remains a significant minority shareholder.